Karyopharm Therapeutics Inc. (KPTI)
USD 3.96
(-1.98%)
USD 3.96
(-1.98%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 141.09 Million USD | -7.44% |
| 2022 | 151.86 Million USD | -26.43% |
| 2021 | 206.41 Million USD | 95.88% |
| 2020 | 105.38 Million USD | 173.81% |
| 2019 | 38.48 Million USD | 129.37% |
| 2018 | -131.03 Million USD | -24.01% |
| 2017 | -105.66 Million USD | -21.76% |
| 2016 | -86.78 Million USD | 10.99% |
| 2015 | -97.49 Million USD | -62.77% |
| 2014 | -59.89 Million USD | -113.43% |
| 2013 | -28.06 Million USD | -108.49% |
| 2012 | -13.46 Million USD | -8955.92% |
| 2011 | 152 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 28.21 Million USD | -9.09% |
| 2024 Q1 | 31.12 Million USD | -3.27% |
| 2024 Q2 | 41.23 Million USD | 32.44% |
| 2023 Q2 | 36.38 Million USD | -2.58% |
| 2023 Q1 | 37.34 Million USD | 17.77% |
| 2023 FY | 140.56 Million USD | -7.44% |
| 2023 Q4 | 32.18 Million USD | -8.3% |
| 2023 Q3 | 35.09 Million USD | -3.54% |
| 2022 Q1 | 46.24 Million USD | -63.16% |
| 2022 FY | 151.86 Million USD | -26.43% |
| 2022 Q4 | 31.71 Million USD | -9.82% |
| 2022 Q3 | 35.16 Million USD | -9.23% |
| 2022 Q2 | 38.74 Million USD | -16.23% |
| 2021 FY | 206.41 Million USD | 95.88% |
| 2021 Q1 | 22.32 Million USD | -34.42% |
| 2021 Q2 | 21.46 Million USD | -3.87% |
| 2021 Q4 | 125.52 Million USD | 238.35% |
| 2021 Q3 | 37.1 Million USD | 72.86% |
| 2020 Q4 | 34.04 Million USD | 62.95% |
| 2020 FY | 105.38 Million USD | 173.81% |
| 2020 Q1 | 17.31 Million USD | 3.69% |
| 2020 Q2 | 33.11 Million USD | 91.22% |
| 2020 Q3 | 20.89 Million USD | -36.91% |
| 2019 Q1 | -37.81 Million USD | 2.24% |
| 2019 Q3 | 12.13 Million USD | 171.29% |
| 2019 Q4 | 16.7 Million USD | 37.62% |
| 2019 FY | 38.48 Million USD | 129.37% |
| 2019 Q2 | -17.02 Million USD | 54.99% |
| 2018 Q1 | -31.32 Million USD | 5.94% |
| 2018 Q4 | -38.68 Million USD | -6.9% |
| 2018 Q3 | -36.18 Million USD | -45.67% |
| 2018 Q2 | -24.84 Million USD | 20.68% |
| 2018 FY | -131.03 Million USD | -24.01% |
| 2017 FY | -105.66 Million USD | -21.76% |
| 2017 Q4 | -33.29 Million USD | -31.95% |
| 2017 Q3 | -25.23 Million USD | -9.17% |
| 2017 Q2 | -23.11 Million USD | 3.74% |
| 2017 Q1 | -24.01 Million USD | -16.44% |
| 2016 Q3 | -19.84 Million USD | 19.07% |
| 2016 Q1 | -21.79 Million USD | 9.33% |
| 2016 Q2 | -24.52 Million USD | -12.5% |
| 2016 Q4 | -20.62 Million USD | -3.93% |
| 2016 FY | -86.78 Million USD | 10.99% |
| 2015 Q3 | -25.84 Million USD | 3.75% |
| 2015 Q4 | -24.03 Million USD | 7.0% |
| 2015 Q1 | -20.75 Million USD | -138440.0% |
| 2015 Q2 | -26.85 Million USD | -29.42% |
| 2015 FY | -97.49 Million USD | -62.77% |
| 2014 Q3 | -15.93 Million USD | -21.25% |
| 2014 Q4 | 15 Thousand USD | 100.09% |
| 2014 FY | -59.89 Million USD | -113.43% |
| 2014 Q2 | -13.13 Million USD | -21.56% |
| 2014 Q1 | -10.8 Million USD | -11.79% |
| 2013 Q2 | -5.92 Million USD | -25.25% |
| 2013 Q4 | -9.66 Million USD | -24.94% |
| 2013 FY | -28.06 Million USD | -108.49% |
| 2013 Q3 | -7.73 Million USD | -30.56% |
| 2013 Q1 | -4.73 Million USD | -30.25% |
| 2012 FY | -13.46 Million USD | -8955.92% |
| 2012 Q4 | -3.63 Million USD | -10785.29% |
| 2012 Q3 | 34 Thousand USD | 0.0% |
| 2011 FY | 152 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | -17.113% |
| Jaguar Health, Inc. | 7.72 Million USD | -1726.657% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 21348.645% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2821920.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 90.705% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -17.818% |
| ContextLogic Inc. | 59 Million USD | -139.137% |
| MiMedx Group, Inc. | 266.84 Million USD | 47.126% |
| MEI Pharma, Inc. | 49.32 Million USD | -186.032% |
| AlloVir, Inc. | -398 Thousand USD | 35550.0% |
| Novavax, Inc. | 639.93 Million USD | 77.952% |
| Aptorum Group Limited | -1.11 Million USD | 12757.443% |
| Ardelyx, Inc. | 106.66 Million USD | -32.28% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 41.392% |
| Psyence Biomedical Ltd. | -240.00 USD | 58788016.667% |
| Vaxcyte, Inc. | -75 Million USD | 288.121% |
| Precigen, Inc. | 106 Thousand USD | -133004.717% |
| Pharming Group N.V. | 220.1 Million USD | 35.898% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -27296.311% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13883.251% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -28.531% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 177.776% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 27403.743% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 208.934% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 411.287% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 741.702% |
| Acelyrin, Inc. | -115 Thousand USD | 122787.826% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 24809.457% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5358.703% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3382.868% |
| AbCellera Biologics Inc. | 38.02 Million USD | -271.048% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 3040.621% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -117475.833% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -384.366% |
| Chimerix, Inc. | 324 Thousand USD | -43446.605% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -28345.766% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 172162.195% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 552.684% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 28777.033% |
| Elevation Oncology, Inc. | -39 Thousand USD | 361871.795% |
| Alkermes plc | 1.37 Billion USD | 89.736% |
| Fortress Biotech, Inc. | 57.85 Million USD | -143.878% |
| Fortress Biotech, Inc. | 57.85 Million USD | -143.878% |
| Agenus Inc. | 139.61 Million USD | -1.057% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -751.125% |
| Dyadic International, Inc. | 922.95 Thousand USD | -15186.844% |
| ImmuCell Corporation | 4.39 Million USD | -3109.324% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -569.916% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 232.95% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 80795.824% |
| Immix Biopharma, Inc. | -5468.00 USD | 2580403.584% |
| Incyte Corporation | 3.44 Billion USD | 95.899% |
| IO Biotech, Inc. | -756 Thousand USD | 18762.831% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 401.225% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1156.24% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 319397.094% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 243.652% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 256629.091% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -17492.394% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 26872.486% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -380.114% |
| NextCure, Inc. | -3.68 Million USD | 3929.832% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -640.907% |
| Onconetix, Inc. | -1.12 Million USD | 12617.333% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 587.058% |
| Opthea Limited | 21.72 Thousand USD | -649490.239% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 246220.434% |
| PureTech Health plc | -1.6 Million USD | 8901.684% |
| Pyxis Oncology, Inc. | -2 Million USD | 7154.55% |
| Seer, Inc. | 7.02 Million USD | -1907.841% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1403850.871% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1692.542% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3679.129% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -33176.179% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -35.535% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -4.304% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 245.53% |
| ChromaDex Corporation | 50.78 Million USD | -177.848% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 60915.086% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 281.823% |
| CRISPR Therapeutics AG | 240.95 Million USD | 41.445% |
| Precision BioSciences, Inc. | 40.47 Million USD | -248.614% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 243.731% |
| Innoviva, Inc. | 261.06 Million USD | 45.956% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6982.488% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -3122.727% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -554.867% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 119173.179% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 98557.792% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -23067.652% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 55.02% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5381.391% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 278166.614% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2087.757% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 29831.848% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1356744.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -144889.775% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1405.31% |
| Kura Oncology, Inc. | -849 Thousand USD | 16718.492% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 310.257% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 96080.272% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -42.46% |
| Autolus Therapeutics plc | -4.86 Million USD | 2998.932% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -240.915% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 84082.738% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -48.951% |
| GRI Bio, Inc. | 10.84 Million USD | -1201.457% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5454.794% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1724.163% |
| IGM Biosciences, Inc. | -211.66 Million USD | 166.659% |
| INmune Bio, Inc. | 155 Thousand USD | -90926.452% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -127.79% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9466.782% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21858.058% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 482066.933% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -34997.264% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 7168.687% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 45176.997% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -49.364% |
| Verastem, Inc. | -62 Thousand USD | 227666.129% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5694.292% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 54157.854% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4561.084% |
| Histogen Inc. | 3.76 Million USD | -3643.46% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -24387.355% |
| Surrozen, Inc. | -27.23 Million USD | 618.145% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2718.13% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11809.963% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 650.127% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -603.626% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 7125908.081% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2225.769% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 210272.648% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 8.851% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -96670.233% |
| Apollomics, Inc. | 127 Thousand USD | -110995.276% |
| Amarin Corporation plc | 165.54 Million USD | 14.77% |
| Mesoblast Limited | -9.81 Million USD | 1537.504% |
| Turnstone Biologics Corp. | 16.5 Million USD | -754.786% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 227.697% |
| Synaptogenix, Inc. | -6347.00 USD | 2223055.727% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 276749.02% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 12.564% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 91.973% |
| Better Therapeutics, Inc. | -2.72 Million USD | 5270.062% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 225.793% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 58.267% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1236872.44% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2353.85% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12833.845% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1827.999% |
| Insmed Incorporated | 239.63 Million USD | 41.123% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3843.292% |
| OmniAb, Inc. | 14.66 Million USD | -861.962% |
| Alector, Inc. | -95.05 Million USD | 248.434% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -12.315% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 424.623% |
| Zai Lab Limited | 170.9 Million USD | 17.444% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -72.321% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10995.058% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -108431.538% |
| Immunic, Inc. | -111 Thousand USD | 127209.009% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -789.939% |
| Veracyte, Inc. | 248.14 Million USD | 43.142% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 102.019% |
| FibroGen, Inc. | 128.9 Million USD | -9.454% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 25016234.752% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1309.329% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 95.849% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -36170.18% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 60.295% |
| TG Therapeutics, Inc. | 219.1 Million USD | 35.607% |
| Galecto, Inc. | -830 Thousand USD | 17098.916% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 10287.076% |
| Fortrea Holdings Inc. | 424 Million USD | 66.724% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 263.741% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 24983.774% |
| XBiotech Inc. | -1.74 Million USD | 8190.08% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12833.845% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 403.611% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 286.791% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -92.214% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -739.677% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 63.734% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 384.188% |
| Vaxxinity, Inc. | -2.23 Million USD | 6415.622% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 56.82% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1345.964% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -477.036% |
| NexImmune, Inc. | -1.02 Million USD | 13865.352% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2612696.296% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2085.615% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.752% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 211228.735% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 4073.275% |
| Ainos, Inc. | -253.73 Thousand USD | 55706.09% |
| Pluri Inc. | 322 Thousand USD | -43717.081% |
| Prothena Corporation plc | -129.2 Million USD | 209.203% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -179.81% |
| Celularity Inc. | 6.75 Million USD | -1988.69% |
| Rallybio Corporation | -150 Thousand USD | 94160.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | 532.702% |
| MeiraGTx Holdings plc | 287 Thousand USD | -49060.627% |
| Omeros Corporation | -69.77 Million USD | 302.197% |
| Humacyte, Inc. | -76.55 Million USD | 284.312% |
| Immunocore Holdings plc | 248.39 Million USD | 43.198% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 1030.127% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -126.173% |
| Blueprint Medicines Corporation | 236.58 Million USD | 40.363% |
| CalciMedica, Inc. | -58 Thousand USD | 243360.345% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9994.18% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -385.6% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 5061.006% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 557.123% |
| Pulmatrix, Inc. | -8.22 Million USD | 1816.436% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 12159.06% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 35461.153% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 135.379% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4983.289% |
| Cytokinetics, Incorporated | -322.59 Million USD | 143.737% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16265.872% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 41475.66% |
| Vor Biopharma Inc. | -3.49 Million USD | 4140.407% |
| Roivant Sciences Ltd. | 109.23 Million USD | -29.163% |
| Evogene Ltd. | 1.39 Million USD | -9985.132% |
| ProKidney Corp. | -3.16 Million USD | 4552.225% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 421.304% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1957.62% |
| CorMedix Inc. | -205.56 Thousand USD | 68736.713% |
| BioLineRx Ltd. | 1.1 Million USD | -12633.845% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 279.343% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 427648.485% |
| Atai Life Sciences N.V. | -5000.00 USD | 2821920.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 115882.174% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 147069.792% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 10257.739% |
| Sagimet Biosciences Inc. | 2 Million USD | -6954.55% |
| MediciNova, Inc. | 979.7 Thousand USD | -14301.376% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 267.33% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 149315.8% |
| GeoVax Labs, Inc. | -20.72 Million USD | 780.916% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 42.302% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3458.51% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 83.826% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1799.96% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 45613.226% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1175858.333% |
| Absci Corporation | -41.84 Million USD | 437.143% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2821920.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 284.739% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5833.076% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 33.988% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 15093.73% |
| Allakos Inc. | -6.14 Million USD | 2397.525% |
| Imunon, Inc. | -720 Thousand USD | 19695.836% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 304.492% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 70.352% |
| BioAtla, Inc. | -103.73 Million USD | 236.016% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1236872.44% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 79364.607% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 158.105% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 45466.881% |
| XOMA Corporation | 3.86 Million USD | -3554.261% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 301.314% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -853.704% |
| aTyr Pharma, Inc. | -2.38 Million USD | 6008.333% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -1032.352% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 486620.69% |
| Viridian Therapeutics, Inc. | -1 Million USD | 14097.123% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1085315284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 3527375.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 77.847% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -72362.867% |
| UroGen Pharma Ltd. | 73.35 Million USD | -92.348% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 628.549% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1215154.091% |
| Orgenesis Inc. | -5.72 Million USD | 2564.472% |
| Entera Bio Ltd. | -56 Thousand USD | 252048.214% |
| GH Research PLC | -315 Thousand USD | 44890.794% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 74751.323% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 26974.476% |
| Xencor, Inc. | -85.26 Million USD | 265.483% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 63948.726% |
| Replimune Group, Inc. | -2.65 Million USD | 5414.162% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 14191.683% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 20.666% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -72362.867% |
| Portage Biotech Inc. | -54 Thousand USD | 261379.63% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 149315.8% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 37524.668% |
| OncoCyte Corporation | 413 Thousand USD | -34062.47% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3138943.159% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 63554604.505% |
| Purple Biotech Ltd. | -196 Thousand USD | 72085.204% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1473.272% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1342.353% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1450.805% |
| HilleVax, Inc. | -2.15 Million USD | 6644.109% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 145554.639% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 940455.905% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 21221.407% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 613539.13% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1879769.498% |
| Savara Inc. | -44.26 Million USD | 418.763% |
| Curis, Inc. | 9.81 Million USD | -1338.09% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4994.417% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 113164.557% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 8260.266% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 61982.018% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.213% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 5146.354% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 135.302% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -148.89% |
| Erasca, Inc. | -3.73 Million USD | 3880.573% |
| bluebird bio, Inc. | -4.03 Million USD | 3601.017% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 500103.544% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.591% |
| DBV Technologies S.A. | 15.72 Million USD | -797.069% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 500103.544% |
| Moderna, Inc. | 2.15 Billion USD | 93.453% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 15519.781% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1662.316% |
| Molecular Templates, Inc. | 50.39 Million USD | -179.97% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 26422.948% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -5.459% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2367.615% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 458.618% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 226.963% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 4032.302% |
| MacroGenics, Inc. | 50.52 Million USD | -179.239% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2413.726% |
| Prime Medicine, Inc. | -147.9 Million USD | 195.393% |
| Aditxt, Inc. | -111.66 Thousand USD | 126457.693% |
| Adagene Inc. | 18.11 Million USD | -679.014% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -28812.09% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -0.634% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 10.609% |
| SciSparc Ltd. | 2.19 Million USD | -6324.909% |
| Vericel Corporation | 135.57 Million USD | -4.068% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 563360.01% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 455496.682% |
| Generation Bio Co. | -73.91 Million USD | 290.893% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 32386.27% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -158.319% |
| Invivyd, Inc. | -2.02 Million USD | 7057.15% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 146.899% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 136501.516% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -46.409% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -43.549% |
| ADMA Biologics, Inc. | 88.21 Million USD | -59.934% |
| Clene Inc. | 533 Thousand USD | -26371.107% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -485.217% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14843.051% |
| GeoVax Labs, Inc. | -20.72 Million USD | 780.916% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6997.133% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 72709.049% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -183.287% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2089.439% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16976.914% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -69.143% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -192879.265% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -165.398% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 181.467% |
| Trevena, Inc. | 1.45 Million USD | -9596.976% |
| Surrozen, Inc. | -27.23 Million USD | 618.145% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 40069.122% |
| Cingulate Inc. | -582.91 Thousand USD | 24304.262% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 455232.258% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 816.234% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1863917.701% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 16114.869% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 79.273% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 14380.466% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 250518.87% |
| Kronos Bio, Inc. | 1.37 Million USD | -10183.601% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 362.906% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 48418.836% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 28993.499% |
| ImmunityBio, Inc. | -17.89 Million USD | 888.658% |
| Korro Bio, Inc. | -3.63 Million USD | 3986.804% |
| Kineta, Inc. | 5.43 Million USD | -2496.926% |
| BioVie Inc. | -229.37 Thousand USD | 61610.526% |
| Codexis, Inc. | 57.33 Million USD | -146.086% |
| Celularity Inc. | 6.75 Million USD | -1988.69% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3415.848% |
| Celcuity Inc. | -142.77 Thousand USD | 98922.598% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -278791.085% |
| Cibus, Inc. | 1.42 Million USD | -9822.011% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 37824.866% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 715.607% |
| IN8bio, Inc. | -2.5 Million USD | 5741.383% |
| Kodiak Sciences Inc. | -25.94 Million USD | 643.766% |
| Annexon, Inc. | -3.26 Million USD | 4418.672% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 7002.691% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 438.048% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -21945.469% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 81.877% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 18.423% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7525.842% |
| Arcellx, Inc. | 108.27 Million USD | -30.303% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 535.883% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -78.136% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 767.034% |
| Moolec Science SA | -143.3 Thousand USD | 98555.043% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 433.407% |
| Geron Corporation | -123.5 Million USD | 214.241% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4192.394% |
| Royalty Pharma plc | 1.79 Billion USD | 92.135% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 301.3% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3906273.865% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -60875.146% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 226.637% |
| Humacyte, Inc. | -76.55 Million USD | 284.312% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14964.609% |
| 89bio, Inc. | -273 Thousand USD | 51781.685% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 11324.423% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 16738.09% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 114808.13% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -12508.668% |
| Notable Labs, Ltd. | 113 Thousand USD | -124759.292% |
| Liquidia Corporation | 14.6 Million USD | -866.377% |
| Mustang Bio, Inc. | -2.22 Million USD | 6441.169% |
| Immunovant, Inc. | -231 Thousand USD | 61178.355% |
| Quantum-Si incorporated | 488 Thousand USD | -28812.09% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 353.948% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 470403.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7477.39% |
| Acasti Pharma Inc. | -11 Thousand USD | 1282745.455% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 69053.704% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21858.058% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 184.227% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -12335.527% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 37131.759% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 7305.873% |
| PepGen Inc. | -1.18 Million USD | 12016.47% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 111195.276% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.184% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 716.199% |
| Solid Biosciences Inc. | -76.56 Million USD | 284.281% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 170947.511% |
| Immuneering Corporation | -764.13 Thousand USD | 18564.073% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -212822.552% |
| Belite Bio, Inc | -399 Thousand USD | 35461.153% |
| XOMA Corporation | 3.86 Million USD | -3554.261% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 804.187% |
| Bionomics Limited | -434.44 Thousand USD | 32575.849% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13236.965% |
| uniQure N.V. | 2.21 Million USD | -6269.797% |
| Cassava Sciences, Inc. | -89.42 Million USD | 257.779% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 253.245% |
| Forte Biosciences, Inc. | -9000.00 USD | 1567777.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16997.126% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 32386.27% |
| Altimmune, Inc. | -65.37 Million USD | 315.825% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 61.028% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 13236.965% |
| Compugen Ltd. | 31.45 Million USD | -348.549% |
| Peak Bio, Inc. | 367.76 Thousand USD | -38264.027% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -475.506% |
| Benitec Biopharma Inc. | 108 Thousand USD | -130539.815% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 180985.897% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11828.263% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7843.743% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 118663.866% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11828.263% |
| Instil Bio, Inc. | -4.75 Million USD | 3066.59% |
| argenx SE | 1.1 Billion USD | 87.272% |
| Immunome, Inc. | -8.9 Million USD | 1684.046% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7565.132% |
| Verona Pharma plc | -679.62 Thousand USD | 20860.156% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 80723.429% |
| Shattuck Labs, Inc. | -2.38 Million USD | 6015.765% |
| CervoMed Inc. | -1.29 Million USD | 11006.621% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5961.695% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 3053.548% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5609.875% |
| Moolec Science SA | -143.3 Thousand USD | 98555.043% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 34678.585% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5381.285% |
| AnaptysBio, Inc. | 14.78 Million USD | -854.543% |
| Design Therapeutics, Inc. | -537 Thousand USD | 26373.929% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 33142.389% |
| NeurAxis, Inc. | 2.15 Million USD | -6441.973% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6474.604% |
| Lumos Pharma, Inc. | 2 Million USD | -6929.945% |
| Achilles Therapeutics plc | -4.73 Million USD | 3082.098% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 80723.429% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 133614.076% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -345.662% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -16265.872% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13771.609% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 409.763% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -328018.605% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 17264.355% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1072383.022% |
| Palisade Bio, Inc. | 246 Thousand USD | -57254.065% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 427648.485% |
| Beam Therapeutics Inc. | -59.67 Million USD | 336.444% |
| Neurogene Inc. | -3.26 Million USD | 4425.291% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -1.26% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3921.533% |
| Sesen Bio, Inc. | 40 Million USD | -252.728% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 47605.387% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3603.593% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1574.922% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -902.067% |
| Athira Pharma, Inc. | -969 Thousand USD | 14660.475% |
| Vaccinex, Inc. | -16 Million USD | 981.598% |
| HCW Biologics Inc. | -574.82 Thousand USD | 24645.078% |
| XOMA Corporation | 3.86 Million USD | -3554.261% |
| Nektar Therapeutics | 53.47 Million USD | -163.83% |
| Arvinas, Inc. | 71.8 Million USD | -96.506% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 269.05% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 324.757% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 43917.081% |
| Rezolute, Inc. | -36 Thousand USD | 392019.444% |
| Clene Inc. | 533 Thousand USD | -26371.107% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10988495.639% |
| BeyondSpring Inc. | 1.75 Million USD | -7957.738% |
| Synlogic, Inc. | -1.92 Million USD | 7433.212% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 381427.027% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2328.222% |
| Peak Bio, Inc. | 367.76 Thousand USD | -38264.027% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 844.033% |
| Krystal Biotech, Inc. | 47.6 Million USD | -196.379% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2707.781% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5549.172% |
| MannKind Corporation | 136.19 Million USD | -3.598% |
| Ikena Oncology, Inc. | -50.49 Million USD | 379.432% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -29.663% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3317.583% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 56088.492% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2821920.0% |
| Legend Biotech Corporation | 140.92 Million USD | -0.115% |
| Mural Oncology plc | -2.56 Million USD | 5596.338% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 25706.352% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 141191.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -579.826% |
| REGENXBIO Inc. | 53.02 Million USD | -166.064% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2733.792% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 73441.65% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 8246.132% |
| Vaxart, Inc. | -60.76 Million USD | 332.199% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 53791.681% |
| Cellectis S.A. | 18 Thousand USD | -783738.889% |
| Longeveron Inc. | 221 Thousand USD | -63742.081% |
| Repare Therapeutics Inc. | -80.07 Million USD | 276.21% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.091% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 11003.478% |
| Revolution Medicines, Inc. | -399.66 Million USD | 135.302% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 403217.143% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -287840.816% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.361% |
| Denali Therapeutics Inc. | -93.34 Million USD | 251.15% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 563360.01% |
| Veru Inc. | 7.56 Million USD | -1764.821% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 93537.748% |
| Cingulate Inc. | -582.91 Thousand USD | 24304.262% |
| Passage Bio, Inc. | -3.72 Million USD | 3891.75% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1171562.969% |
| Exicure, Inc. | -1.42 Million USD | 10015.039% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 36938.381% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -5119.793% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 27620.554% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -107.103% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 94407.753% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 338.305% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -35984.655% |
| OmniAb, Inc. | 14.66 Million USD | -861.962% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -605.702% |
| Lipocine Inc. | -2.85 Million USD | 5049.141% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7755.507% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2573.111% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9466.782% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -87.332% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 217163.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -67.376% |
| Ocugen, Inc. | -33.53 Million USD | 520.703% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4562.081% |
| Q32 Bio Inc. | 578 Thousand USD | -24310.208% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 53341.887% |
| Alumis Inc. Common Stock | -1.28 Million USD | 11088.396% |
| Equillium, Inc. | 35.95 Million USD | -292.377% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 8365.436% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -28079.932% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3413041.461% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 54575.29% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -33277.571% |
| Dominari Holdings Inc. | 2.03 Million USD | -6819.617% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 77000.982% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1137.815% |
| Bio-Techne Corporation | 773.07 Million USD | 81.749% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -714.66% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 69.38% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 12169.376% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 688.369% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1106.215% |
| Nkarta, Inc. | -5.86 Million USD | 2504.004% |
| BioCardia, Inc. | -7.24 Million USD | 2046.351% |
| Iterum Therapeutics plc | -1.75 Million USD | 8162.343% |